Seward & Kissel Expands Capital Markets and Corporate Securities Group with Addition of Holt Goddard as Counsel

November 8, 2022

New York—November 8, 2022—Seward & Kissel LLP announced today that Holt Goddard, most recently general counsel of an international biotech company, has joined the firm as counsel in the Capital Markets and Corporate Securities Group in New York.

Holt has extensive experience in capital markets, with a particular focus on IPOs and high yield bond offerings. He has represented issuers and underwriters in a wide variety of industries, including shipping, retail, life sciences, and media, working with issuers both within the United States and abroad. In addition to his capital markets work, he has assisted clients with mergers & acquisitions, restructurings, bank loans, SPAC transactions, and SEC reporting.

“Holt’s experience in the capital markets space, coupled with his recent in-house counsel role, will make him an invaluable asset to our clients,” said Keith Billotti, partner in the Capital Markets and Corporate Securities Group.

Partner Ted Horton added, “We are thrilled to have Holt on board to further support our group as we advise clients on nearly every type of capital markets transactions, public company reporting obligations, and governance matters.”

Prior to joining Seward & Kissel, Holt served as general counsel of international biotechnology company HUYABIO International and was previously a partner at White & Case. He received his J.D. from Columbia Law School and his M.B.A. from Yale School of Management.